JP2014528715A5 - - Google Patents

Download PDF

Info

Publication number
JP2014528715A5
JP2014528715A5 JP2014530916A JP2014530916A JP2014528715A5 JP 2014528715 A5 JP2014528715 A5 JP 2014528715A5 JP 2014530916 A JP2014530916 A JP 2014530916A JP 2014530916 A JP2014530916 A JP 2014530916A JP 2014528715 A5 JP2014528715 A5 JP 2014528715A5
Authority
JP
Japan
Prior art keywords
coth
polypeptide
seq
fungal
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014530916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014528715A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/055659 external-priority patent/WO2013040517A2/en
Publication of JP2014528715A publication Critical patent/JP2014528715A/ja
Publication of JP2014528715A5 publication Critical patent/JP2014528715A5/ja
Pending legal-status Critical Current

Links

JP2014530916A 2011-09-15 2012-09-14 CotHを用いたムコール菌症の免疫療法および診断法 Pending JP2014528715A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161535257P 2011-09-15 2011-09-15
US61/535,257 2011-09-15
PCT/US2012/055659 WO2013040517A2 (en) 2011-09-15 2012-09-14 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH

Publications (2)

Publication Number Publication Date
JP2014528715A JP2014528715A (ja) 2014-10-30
JP2014528715A5 true JP2014528715A5 (cg-RX-API-DMAC10.html) 2015-11-05

Family

ID=47884011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014530916A Pending JP2014528715A (ja) 2011-09-15 2012-09-14 CotHを用いたムコール菌症の免疫療法および診断法

Country Status (7)

Country Link
US (3) US9279002B2 (cg-RX-API-DMAC10.html)
EP (1) EP2755681B1 (cg-RX-API-DMAC10.html)
JP (1) JP2014528715A (cg-RX-API-DMAC10.html)
CN (1) CN103998057A (cg-RX-API-DMAC10.html)
AU (1) AU2012308240A1 (cg-RX-API-DMAC10.html)
CA (1) CA2848765A1 (cg-RX-API-DMAC10.html)
WO (1) WO2013040517A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10465233B2 (en) * 2016-03-25 2019-11-05 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Time-resolved nucleic acid hybridization beacons
WO2017197386A1 (en) * 2016-05-13 2017-11-16 The Brigham And Women's Hospital, Inc. Volatile metabolite profiles for the diagnosis and treatment of mucorales fungi
US10877037B2 (en) 2016-11-21 2020-12-29 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Fungal toxins and methods related to the same
EP4334344A4 (en) * 2021-05-06 2025-07-02 Lundquist Inst For Biomedical Innovation At Harbor Ucla Medical Center COTH3 BINDING AGENTS AND THEIR USES
CN114324896A (zh) * 2021-12-31 2022-04-12 菲鹏生物股份有限公司 特异性结合mucoricin蛋白的试剂的用途和毛霉菌检测试剂盒
CN114568490B (zh) * 2022-04-01 2023-12-19 眉山职业技术学院(眉山技师学院) 雷帕霉素在抑制柑橘青霉菌生长中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405712A (en) 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4493795A (en) 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
JP2561478B2 (ja) 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
ATE110108T1 (de) 1987-12-11 1994-09-15 Whitehead Biomedical Inst Genetische modifizierung von endothelialen zellen.
JPH04507041A (ja) 1988-12-13 1992-12-10 アメリカ合衆国 遺伝工学により修飾された内皮細胞およびその利用方法
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
EP0549723A1 (en) 1990-09-21 1993-07-07 Chiron Corporation Packaging cells
DE69123981T3 (de) 1990-10-31 2006-06-14 Cell Genesys Inc Nützliche retrovirale vektoren für die gentherapie
ATE188740T1 (de) 1991-02-19 2000-01-15 Univ California Viruspartikel mit veraendertem wirtspektrum
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US7914799B2 (en) * 2001-08-27 2011-03-29 Immunitor USA, Inc. Anti-fungal composition
GB0205378D0 (en) * 2002-03-07 2002-04-24 Royal Holloway University Of L Bacterial spores
WO2008017483A2 (en) * 2006-08-09 2008-02-14 Dsm Ip Assets B.V. Spore surface displays of bioactive molecules
EP2271366A4 (en) * 2008-02-28 2012-06-20 3M Innovative Properties Co ANTIBODIES DIFFICULT CLOSTRIDIUM SPORES AND USES THEREOF
JP2012520878A (ja) * 2009-03-19 2012-09-10 ロサンゼルス ビオメドイカル リサーチ インストイトウテ アト ハルボル‐ユーシーエルエー メドイカル センテル ムコール菌症、及びその他の真菌疾患の治療のためのワクチン組成物、及び方法
US20110059111A1 (en) * 2009-09-01 2011-03-10 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Mammalian receptors as targets for antibody and active vaccination therapy against mold infections

Similar Documents

Publication Publication Date Title
JP2012000112A5 (cg-RX-API-DMAC10.html)
RU2012107993A (ru) Полипептиды porhyromonas gingivalis
MX2014001375A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340014B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340015B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
NZ713461A (en) Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
IN2014KN01713A (cg-RX-API-DMAC10.html)
IN2014KN01714A (cg-RX-API-DMAC10.html)
IN2014KN01716A (cg-RX-API-DMAC10.html)
IN2014KN01715A (cg-RX-API-DMAC10.html)
JP2015532644A5 (cg-RX-API-DMAC10.html)
JP2013501007A5 (cg-RX-API-DMAC10.html)
NZ600348A (en) Anti-c5a binding moieties with high blocking activity
CA2813849C (en) Secukinumab for use in the treatment of ankylosing spondylitis
JP2012126742A5 (cg-RX-API-DMAC10.html)
RU2015119517A (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
JP2015525208A5 (cg-RX-API-DMAC10.html)
AR098743A1 (es) Anticuerpos e inmunoconjugados anti-cd33
JP2008525033A5 (cg-RX-API-DMAC10.html)
EA201500802A1 (ru) Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы
RU2016107814A (ru) Новое антитело к tslp-рецептору человека
NZ630847A (en) Anti-sema4d antibodies and epitopes
AR078377A1 (es) Anticuerpos anti-vegf-c (factor de crecimiento endotelial anti-vascular aislado c) y sus metodos de uso
JP2012529293A5 (cg-RX-API-DMAC10.html)